Back to Gene
FH gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

FH gene

The FH gene provides instructions for making the enzyme fumarase, which is critical for cellular energy production.

Normal Function

The FH gene provides instructions for making an enzyme called fumarase (also known as fumarate hydratase). Fumarase participates in an important series of reactions known as the citric acid cycle or Krebs cycle, which allows cells to use oxygen and generate energy. Specifically, fumarase helps convert a molecule called fumarate to a molecule called malate.

Health Conditions Related to Genetic Changes

Fumarase deficiency

More than 20 FH gene mutations have been identified in people with fumarase deficiency, a condition that primarily affects the brain and is often fatal in infancy. Fumarase deficiency occurs in individuals who inherit two mutated copies of the FH gene in each cell. These mutations disrupt the enzyme's ability to convert fumarate to malate, impairing the process that generates energy for cells, which is particularly harmful to the developing brain.

Hereditary leiomyomatosis and renal cell cancer

More than 70 mutations in the FH gene cause hereditary leiomyomatosis and renal cell cancer (HLRCC). This disorder is characterized by:

  • Leiomyomas: Benign tumors containing smooth muscle tissue in the skin and, in females, the uterus.
  • Kidney cancer: An increased risk of developing renal cell cancer.

People with HLRCC are born with one mutated copy of the FH gene. The second copy may acquire a somatic mutation later in life due to environmental factors or DNA replication errors. These mutations may lead to a buildup of fumarate, which researchers believe interferes with the regulation of oxygen levels in the cell. Chronic oxygen deficiency (hypoxia) in these cells may encourage tumor formation.

Primary macronodular adrenal hyperplasia

The FH gene is also associated with primary macronodular adrenal hyperplasia.

Other Names for This Gene

  • fumarase
  • fumarase hydratase
  • FUMH_HUMAN
  • HLRCC
  • LRCC
  • MCL
  • MCUL1

Frequently Asked Questions

Early signs of HLRCC include the appearance of multiple skin or uterine leiomyomas (benign smooth‑muscle tumors), especially in women, and a family history of kidney cancer. If you notice sudden, painless kidney masses on imaging, unexplained hematuria (blood in urine), or a rapid increase in the size of known leiomyomas, you should seek prompt medical evaluation and consider renal imaging and genetic testing.
While no diet can eliminate genetic risk, maintaining a healthy body weight, limiting processed foods, and ensuring adequate hydration can support kidney health. Regular blood pressure monitoring, avoiding nephrotoxic medications (e.g., certain NSAIDs), and staying up to date with recommended imaging (e.g., annual MRI or ultrasound of the kidneys) can help detect early changes. Discussing a personalized surveillance plan with a nephrologist or oncologist is advisable.
The most common approach is a targeted next‑generation sequencing panel that includes the FH gene, followed by confirmation with Sanger sequencing if a variant is identified. Some labs also perform a copy‑number variation analysis to detect large deletions or duplications. Prior to testing, you should have a pre‑test counseling session to understand the implications of a positive result, potential insurance coverage, and the possibility of incidental findings. Ensure your sample (blood or saliva) is collected according to the lab’s instructions to avoid delays.
FH gene mutations are inherited in an autosomal dominant pattern. This means that if you carry one mutated copy of the FH gene, there is a 50% chance you will pass that mutation to each of your children. However, the severity of conditions such as hereditary leiomyomatosis and renal cell cancer (HLRCC) can vary even among family members with the same mutation. Genetic counseling is recommended to discuss reproductive options and the likelihood of disease expression in offspring.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA